Home
Home
CAPture
October 3, 2007 |


CAPture is a selection of recent allergy papers related to the product areas of Phadia. CAPture is issued six times a year.

 

 

 


2010

  • IgE sensitization to peanut storage proteins (Ara h 1-3) is more related to clinical symptoms to peanut than sensitization only to the birch Bet v 1 homolog (Ara h 8)
     
  • Highly purified allergen components increase test specificity in measurement of IgE antibodies to ovomucoid and conalbumin
     
  • The changes and peak values of serum IgE antibodies to soy extracts are related to tolerance development in childhood soy allergy
 
  • A new point-of-care test for primary care physicians to diagnose respiratory atopic allergy – ImmunoCAP® Rapid Wheeze/Rhinitis Child
     
  • IgE to non-glycosylated recombinant venom allergens discriminates between bee and wasp allergy, and will thus improve venom immunotherapy (VIT) 
     
  • Basal serum tryptase increases with age in patients with systemic reaction to Hymenoptera sting and is a risk marker for reaction severity
  • Integration of IgE levels to aeroallergens and the number of lower tract infections before 2 years of age is effective in predicting asthma at 5 years of age
     
  • Peanut sensitization in children without concomitant birch sensitization is of higher clinical relevance
     
  • Sensitization to food and aeroallergens during first year of life is a strong predictor for allergy at the age of 6 years in children with family atopy
 
  • IgE sensitization to peanut allergen Ara h 2 is more useful in predicting clinical peanut allergy than currently used tests based on whole peanut extract
     
  • Component resolved diagnostics (CRD) with individual celery allergen components showed improved test sensitivity in celery allergic patients  
     
  • Phadiatop® Infant as a complement to clinical information in the differential diagnosis in IgE-mediated diseases in young children with allergy-like symptoms